A conversation around the emerging issues in the Biotech industry and how they can impact your future.
“The Sheridan Meeting is a unique opportunity to informally explore with national experts the details of policy making around genetically modified organisms and how it affects our country.”
- David T. Kingsbury, PhD, former chair, Federal Biotechnology Science Coordinating Committee
“The informal setting of the Sheridan Technology Conference provides an opportunity for relaxed dialog about emerging trends in bioinformatics and its impact on genetic medicine and new advances in agriculture.”
- Deborah A. Smeltzer, former biotechnology corporate executive